Business Wire

OH-PROCTER-&-GAMBLE

Share
Procter & Gamble and the IOC Announce an Extension to Their Worldwide Olympic Partnership Through to 2028

As the world marks one year to go until the Olympic Games Tokyo 2020, Procter & Gamble (NYSE:PG) and the International Olympic Committee (IOC) affirmed the company’s commitment to the Olympic and Paralympic Movements, with confirmation of its Worldwide Partnership for the next four Olympic and Paralympic Games. Building upon the success of the last 10 years of partnership and the values shared by both organisations to improve life and create a better world, P&G and the IOC are committing to a first-of-its-kind, citizenship-driven partnership to advance important work in key areas – equality and inclusion, environmental sustainability and community impact – through Los Angeles 2028. For the first time, P&G has also secured global marketing rights to the International Paralympic Committee (IPC) and Paralympic Games through the IOC-IPC long-term collaboration agreement, under which the IOC oversees the IPC and Paralympic Games commercial programmes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200722005270/en/

“As a TOP Partner of the IOC for the past 10 years, we are extremely proud of the work we’ve done together,” said P&G Chief Brand Officer, Marc Pritchard. “As we look forward to the next decade, we recognise the opportunity and the responsibility to use our sponsorship of the Olympic Games for broader impact. In the spirit of the Olympic Movement, we’re making a shared commitment through our partnership to create positive change in the world in the areas of equality and inclusion, environmental sustainability and community impact. We will use each of the next four Games as a milestone to measure progress and leave a meaningful legacy behind.”

IOC President Thomas Bach said: “Procter & Gamble has been a true partner to the IOC and a powerful force in supporting the ideals of the Olympic Movement. As we mark one year to go until the Olympic Games Tokyo 2020, we are delighted to announce that we will be “stronger together” with P&G until 2028. Looking to the future, we have prioritised clear purpose-led initiatives that support the IOC’s vision of building a better world through sport.”

As a global Partner, P&G will continue to support the Olympic and Paralympic Games Tokyo 2020, as well as the Olympic and Paralympic Winter Games Beijing 2022, the Olympic and Paralympic Games Paris 2024, the Olympic and Paralympic Winter Games Milano-Cortina 2026, and the Olympic and Paralympic Games Los Angeles 2028.

Athletes for Good Fund

In line with the IOC’s mission of supporting athletes and putting them at the heart of the Olympic Movement, as part of P&G’s next chapter of Olympic and Paralympic partnership, the company will launch the Athletes for Good Fund , a joint initiative between P&G, the IOC and the IPC that will issue grants to the causes that Olympic and Paralympic Games athletes and hopefuls are supporting to advance important work against shared core citizenship values. The Athletes for Good Fund will award a total of 52 grants over the course of the next year through an application process on the IOC’s Athlete365 platform—representing one for every week leading up to the Opening Ceremony of the Olympic Games Tokyo 2020. Olympic and Paralympic athletes and hopefuls who are working with organisations that are building and serving their communities in the areas of community impact (COVID-19 relief), equality and inclusion, and environmental sustainability are eligible to apply.

The Measure of Greatness

In celebration of the one-year-to-go mark, and for the athletes facing an extended road to the Olympic Games Tokyo 2020, P&G has honoured all existing athlete partnerships, extending many through 2021. Through a digital video series entitled The Measure of Greatness P&G will also highlight the stories of Olympic and Paralympic athletes and hopefuls from around the world who are stepping up to take meaningful action to serve their communities in 2020.

Pritchard continued: “While the world around us may have changed in the last few months, our purpose as an Olympic Games sponsor has not. We’ve always celebrated the journey athletes take on the road to their Olympic dreams and acknowledged the many people who supported them along the way. As part of this new journey to Tokyo, we know that the one-year-to-go moment will take on a new meaning for athletes, their families and fans alike. We remain steadfast in our support for athletes and we are honoured to elevate the stories of exceptional Olympic and Paralympic athletes and hopefuls who have stepped up to lead their communities in 2020 – not through their athletic performances, but through their compassion, their humanity, and their love.”

Shining a light on Olympic and Paralympic athletes and hopefuls who have demonstrated what it means to inspire on and off the field of play, The Measure of Greatness tells the uplifting stories of athletes who have used this moment to step up to a different stage in service to others. From fighting on the front lines in the medical field against the COVID-19 pandemic, to lifting their voices for racial equality, to using their resources to direct medical equipment and food to those most in need, these athletes epitomise how people can lead with love during challenging times.

The Measure of Greatness digital film tells the inspiring athlete stories of the following Olympic and Paralympic athletes and hopefuls:

  • Kim Daybell , Great Britain, Paralympic Table Tennis : Kim was due to start training full time to prepare for Tokyo but instead returned to work full time as a medical SHO (senior house officer) managing COVID-19 patients in a London hospital. He has been working 40-60 hours each week in the hospital, while still staying mentally and physically fit for his continued journey on the road to Tokyo 2020.
  • Simone Manuel, United States, Swimming: As the first Black woman to win an individual medal in Olympic swimming, Simone is an outspoken advocate for challenging racial stereotypes in competitive swimming and has consistently used her platform to educate her followers on how to be actively anti-racist, amplify Black voices and to encourage all people to dream big and beyond stereotypes. Since the outset of the COVID-19 outbreak, Simone has also used her platform to support organizations that connect the food insecure with much-needed meals.
  • Kento Momota, Japan, Badminton: Momota-san donated 10 per cent of his prize money from his 2019 tournament winnings (USD 50,000) to the Tokyo Medical Association in support of COVID-19 relief efforts and helped in the donation of 200,000 masks to students and medical staff in Japan. He has also dedicated his time to mentoring youth badminton players, offering encouragement and motivation as they navigate this time away from sport.
  • Pamphinette (Pam) Buisa, Canada, Rugby: Pam co-organised a peace rally for Black lives in Victoria, Canada, and is a prominent voice in the Canadian athletic community, encouraging others to engage in anti-racist work and equitable reconciliation. Additionally, Pam has joined forces with several women in her community to establish and fundraise for a COVID-19 relief fund for people in need on Vancouver Island.

“While the rescheduling of the Olympic Games was disappointing for me, I immediately realized that there were more important things that needed to be done to help our community, our country and our world. I knew I had an important opportunity to use my voice and my resources to offer support to my community during this unprecedented time,” said Simone Manuel. “Additionally, it has been incredible to witness and participate in a pivotal moment in history where we are collectively fighting for equality for all.”

The Measure of Greatness can be viewed at: https://youtu.be/ZciNNbgXSIA

As part of the partnership, P&G will lend its expertise and thought leadership to the IOC on how to grow, accelerate and bring innovation to the IOC’s digital capabilities, products and assets. This effort supports the IOC’s strategy to engage people with the Olympic brand and maintain long-term relevance both during and outside of Games time.

Jiri Kejval, IOC Marketing Commission Chair, said: “This extension to our agreement with P&G is another clear sign of the enduring appeal of the Worldwide Olympic Partner programme, as well as the commitment of our Partners to support and promote the Olympic values globally. By redistributing 90% of the revenues it generates, the IOC is able to support sport and athletes globally, all year round.”

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks® and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com/ for the latest news and information about P&G and its brands.

About the International Olympic Committee

The International Olympic Committee is a not-for-profit independent international organisation made up of volunteers, which is committed to building a better world through sport. It redistributes more than 90 per cent of its income to the wider sporting movement, which means that every day the equivalent of 3.4 million US dollars goes to help athletes and sports organisations at all levels around the world.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Receives CHMP Positive Opinion for ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 08:03:00 CEST | Press release

- ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor) recommended for people with CF ages 6 years and older with at least one non-class I mutation in the CFTR gene -- In head-to-head clinical trials, deutivacaftor/tezacaftor/vanzacaftor was non-inferior on ppFEV1 and superior compared to KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) at reducing sweat chloride - Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least

Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 07:02:00 CEST | Press release

-- Total deal size of approximately €500 million, including approximately €125 million in upfront and near-term milestones ---- Ferrer to commercialize pridopidine in Europe and other select markets; Prilenia retains full commercialization and development rights to pridopidine in North America, Japan and Asia Pacific ---- Co-development agreement in the territory supports further expansion of pridopidine in Huntington’s disease, amyotrophic lateral sclerosis and future indications ---- Pridopidine for Huntington’s disease is currently under review by the European Medicines Agency (EMA) with a CHMP opinion expected in the second half of 2025 -- Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization

Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine28.4.2025 07:00:00 CEST | Press release

Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V.,a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth of Independent States Region. Pridopidine, a potent and highly selective, orally administered sigma-1 receptor agonist, designed to regulate key neuroprotective mechanisms that are often impaired in neurodegenerative diseases, is a promising candidate for the treatment of Huntington’s Disease (HD), a rare inherited neurodegenerative disease, with a high unmet medical need1. It has been studied in more than 1,700 people and long-term safety data of up to 7 years duration are available from previou

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease27.4.2025 11:36:00 CEST | Press release

Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients. About FDA Designations The Rare Pediatric Disease Designation (RPDD) incentivizes therapies for serious or life-threatening diseases affecting fewer than 200,000 U.S. patients, primarily those aged 18 or younger. Sponsors may qualify for a Priority Review Voucher (PRV) upon approval to expedite FDA review of a subsequent drug application. The Orphan Drug Designation (ODD) supports therapies targeting rare diseases (affecting fewer than 200,000 U.S. patients) by provi

Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 19:00:00 CEST | Press release

Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye